Page last updated: 2024-08-25

rosiglitazone and Antibody Deficiency Syndrome

rosiglitazone has been researched along with Antibody Deficiency Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnal, JF; Authier, H; Auwerx, J; Balard, P; Bernad, J; Coste, A; Douin-Echinard, V; Filipe, C; Galès, A; Lagane, C; Lepert, JC; Linas, MD; Pipy, B1

Other Studies

1 other study(ies) available for rosiglitazone and Antibody Deficiency Syndrome

ArticleYear
IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via peroxisome proliferator-activated receptor-gamma activation.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Apr-01, Volume: 180, Issue:7

    Topics: Animals; Candida albicans; Candidiasis; Cecum; Cell Movement; DNA-Binding Proteins; Female; Gastrointestinal Diseases; Immunologic Deficiency Syndromes; Interleukin-13; Lectins, C-Type; Ligands; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Knockout; PPAR gamma; Receptors, Cell Surface; Rosiglitazone; Thiazolidinediones

2008